Baxion
Screening
Tags
Alerts
Theme
Inhibrx Biosciences, Inc.
INBX
·
NASDAQ
·
$106.85
Share Price as of 11/2
·
$2B
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/13/26
10-Q
Q1 ended 03/31/26
05/14/26
10-K
FY 2025
03/19/26
10-Q
Q3 ended 09/30/25
11/14/25
10-Q
Q2 ended 06/30/25
08/13/25
Disclosures
Filter
8-K
Current report
09/28/26
8-K
Regulation FD Disclosure; Other Events
09/08/26
8-K
Results of Operations
08/13/26
8-K
Entry into Material Agreement; Creation of Direct Financial Obligation; Unregistered Sales of Equity; Regulation FD Disclosure
07/16/26
8-K
Current report
06/15/26
Prospectuses and Registrations
Filter
POS AM
Post-effective amendment
06/02/25
424B3
Prospectus
05/28/25
424B3
Prospectus
05/14/25
POS AM
Post-effective amendment
04/17/25
424B3
Prospectus
04/01/25
Proxies
Filter
DEF 14A
Definitive proxy
04/23/26
DEFA14A
Additional proxy materials
04/23/26
DEF 14A
Definitive proxy
04/16/25
DEFA14A
Additional proxy materials
04/16/25
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
10/28/26
Form 4
Insider transaction
10/14/26
Form 4
Insider transaction
09/28/26
Form 4
Insider transaction
09/23/26
4/A
Insider transaction (amended)
09/18/26
Other
Filter
ARS
Annual report to shareholders
04/23/26
EFFECT
Request for effectiveness
06/04/25
EFFECT
Request for effectiveness
04/18/25
ARS
Annual report to shareholders
04/17/25
EFFECT
Request for effectiveness
06/18/24
Latest Filings
Filter
8-K
Current report
09/28/26
8-K
Regulation FD Disclosure; Other Events
09/08/26
10-Q
Q2 ended 06/30/26
08/13/26
8-K
Results of Operations
08/13/26
8-K
Entry into Material Agreement; Creation of Direct Financial Obligation; Unregistered Sales of Equity; Regulation FD Disclosure
07/16/26
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
10/28/26
Form 4
Insider transaction
10/14/26
Form 4
Insider transaction
09/28/26
Form 4
Insider transaction
09/23/26
4/A
Insider transaction (amended)
09/18/26